To Investigate Efficacy of YAZ in the Treatment of Dysmenorrhea

NCT02617537 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Dysmenorrhea

Interventions

DRUG: EE20/DRSP(YAZ,BAY86-5300)
DRUG: Placebo

Sponsor

Bayer